Pakistan Records 34% Increase in Pharmaceutical and Medical Device Exports

**Islamabad:** Pakistan has witnessed a significant 34% rise in the exports of medicines and medical devices, according to the Drug Regulatory Authority of Pakistan (DRAP).

DRAP attributed this growth to institutional reforms, a transparent regulatory framework, and digital initiatives. The authority stated that an efficient regulatory system has led to billions of rupees in savings, benefiting the public directly. Currently, around 70% of regulatory processes have been digitized, with a target of achieving full digitization by March.

Key measures such as the online medical device registration system, e-office, and one-window facilitation have reduced delays and accelerated certification for exports. Export registration for medicines has been cut from 60 days to just 10 days. Similarly, FSC and COPP certificates, previously issued in 30 days, are now provided within 5 days, while medical device registrations now take approximately 20 days.

DRAP also highlighted initiatives to make Pakistan self-reliant in pharmaceuticals, including fast-track approvals for new therapies and cancer treatment products, the establishment of a national quality control laboratory network, a draft national vaccine policy, and a roadmap for local production of Active Pharmaceutical Ingredients (APIs).

Prime Minister recognized DRAP’s performance in December 2025, awarding the authority the “Reform Champion Award” for its outstanding implementation of reforms.